ExaWizards and ExaMD presented findings from a wearable device study on breast cancer patients at the American Society of Clinical Oncology's ASCO 2026 conference. The research was a joint project involving Kansai Medical University, Daiichi Sankyo, and others.
Summaries like this, in your inbox every morning.
Pick your industry and the AI tools you use, and get news related to your work every day.
Free · 30 seconds with Google · unsubscribe anytimeWhat is AIToday? →
Ask AI anything about this article. The AI reads this article, earlier AIToday articles, and Wikipedia, and cites its sources. Q&As are published on this page for other readers too.
OpenAI introduced the Rosalind Academic Plan, giving eligible academic labs at U.S
Wells Fargo hired an AI executive based in San Francisco, a move The Business Journals describes as part of em…
Amazon launched two Bee "personal AI" devices on Thursday: the $74.99 Bee Frontier wristband and the $99.99 Be…
Apple released MLX today, which runs the 816B-parameter Muse Spark Open on four Mac Studios at over 36 tokens…
Bloom Energy stock fell 4% to $229.83, still up 165% year to date, while Caterpillar slipped 3% to $727.55 and…
LogicMonitor announced its 2026 Elevate Award winners at its Elevate Community Conference in Chicago, honoring…
